Danaher share price today

(DHR)

Danaher share price is $234.34 & ₹19,868.05 as on 11 Dec 2024, 2.30 'hrs' IST

$234.34

▲

-1.57

(-0.67%)

Market is closed - opens 8 PM, 11 Dec 2024

View live Danaher share price in Dollar and Rupees. Guide to invest in Danaher from India. Also see the sentimental analysis on Indian investors investing in Danaher. Get details on the Indian mutual funds that are investing in Danaher. Get Analyst recommendations and forecasts along with all the Danaher's financials.

Danaher share price movements

$234.00
$237.00
$234.34
0.15%
Downside
Day's Volatility :1.27%
Upside
1.12%
$218.48
$281.70
$234.34
6.77%
Downside
52 Weeks Volatility :22.44%
Upside
16.81%

Danaher Returns

Period	Danaher Corp.	Sector (Health Care)	Index (Russel 2000)
3 Months	-13.84%	-7.2%	0.0%
6 Months	-11.44%	-1.5%	0.0%
1 Year	6.64%	8.4%	0.0%
3 Years	-26.43%	7.1%	-20.0%

Danaher Key Statistics

in dollars & INR

Previous Close	$235.91
Open	$236.93
Today's High	$237.0
Today's Low	$234.0
Market Capitalization	$170.4B
Today's Volume	$2.7M
52 Week High	$281.7
52 Week Low	$218.48
Revenue TTM	$23.7B
EBITDA	$7.5B
Earnings Per Share (EPS)	$5.3
PE Ratio	44.22
Dividend Yield	0.46%
Profit Margin	16.39%
Quarterly Earnings Growth YOY	-0.26%
Return On Equity TTM	7.59%

How to invest in Danaher from India?

It is very easy for Indian residents to invest directly in Danaher from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Danaher stock in both rupees (INR) and dollars (USD). Search for Danaher or DHR on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Danaher or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Danaher shares which would translate to 0.004 fractional shares of Danaher as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Danaher

13.19%

Period: Sep 11, 2024 to Dec 10, 2024. Change in 30 Days versus previous period

Investment in Danaher from India has grown in the last 30 days as on Dec 11, 2024. 13.19% more purchase transactions for Danaher in the last 30 days versus the previous period.

-10%

Period: Sep 11, 2024 to Dec 10, 2024. Change in 30 Days versus previous period

Search volume for Danaher on INDmoney from India has reduced in the last 30 days as on Dec 11, 2024. -10% less investors are searching Danaher in the last 30 days versus the previous period.

Indian Mutual Funds that own Danaher

Name	Shares Held	Change in Shares	% of Assets
Motilal Oswal S&P 500 Index Fund Direct Growth	5524	-221.57	0.30%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	935	-55.75	1.23%

Global Institutional Holdings in Danaher

Vanguard Group Inc
8.23%
BlackRock Inc
7.00%
State Street Corp
3.80%
FMR Inc
3.27%
Wellington Management Company LLP
3.23%
T. Rowe Price Associates, Inc.
2.83%

Analyst Recommendation on Danaher

Buy

73%Buy

23%Hold

3%Sell

Based on 30 Wall street analysts offering stock ratings for Danaher(by analysts ranked 0 to 5 stars)

Based on 30 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Danaher

What analysts predicted

Upside of 23.75%

Current:

$234.34

Target:

$290.00

Insights on Danaher

Price Movement
In the last 3 months, DHR stock has moved down by -13.8%
Increasing Revenue
Danaher Corp. has shown consistent revenue growth over the past two quarters. In the latest quarter, the revenue increased from $5.74 billion to $5.79 billion. This reflects an average increase of 1.0% per quarter.
Decreasing Net Profit
Danaher Corp. has experienced a decline in net profit over the last three quarters, decreasing from $1.08 billion to $818 million. This represents an average drop of 13.2% in profit each quarter.
DHR vs A (1 yr)
In the last 1 year, Agilent Technologies Inc. has given 10.0% return, outperforming this stock by 4.1%
DHR vs A (3 yr)
In the last 3 years, Danaher Corp. has experienced a drawdown of -26.2%, however Agilent Technologies Inc. resisted the overall trend and outperformed by 17.0%
Price to Sales
Danaher Corp. is currently valued at a Price-to-Sales Ratio of 7.3, meaning investors are willing to pay $7.3 for every $1 of sales the company generates. In comparison, Agilent Technologies Inc. has a lower Price-to-Sales Ratio of 6.4, indicating that investors are paying less for each dollar of sales compared to Danaher Corp.

Danaher Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$19.9B	↑ 8.53%
Net Income	$2.7B	↑ 6.37%
Net Profit Margin	13.33%	↓ 0.27%

	FY19	Y/Y Change
Revenue	$17.9B	↓ 9.96%
Net Income	$3.0B	↑ 13.48%
Net Profit Margin	16.8%	↑ 3.47%

	FY20	Y/Y Change
Revenue	$22.3B	↑ 24.41%
Net Income	$3.6B	↑ 21.2%
Net Profit Margin	16.36%	↓ 0.44%

	FY21	Y/Y Change
Revenue	$29.5B	↑ 32.17%
Net Income	$6.4B	↑ 76.44%
Net Profit Margin	21.84%	↑ 5.48%

	FY22	Y/Y Change
Revenue	$31.5B	↑ 6.85%
Net Income	$7.2B	↑ 12.06%
Net Profit Margin	22.91%	↑ 1.07%

	FY23	Y/Y Change
Revenue	$23.9B	↓ 24.09%
Net Income	$4.7B	↓ 34.21%
Net Profit Margin	19.85%	↓ 3.06%

	Q2 FY23	Q/Q Change
Revenue	$7.2B	↓ 0.14%
Net Income	$1.1B	↓ 23.72%
Net Profit Margin	15.45%	↓ 4.78%

	Q3 FY23	Q/Q Change
Revenue	$6.9B	↓ 3.97%
Net Income	$1.1B	↑ 2.08%
Net Profit Margin	16.43%	↑ 0.98%

	Q4 FY23	Q/Q Change
Revenue	$2.7B	↓ 60.82%
Net Income	$1.1B	↓ 4.43%
Net Profit Margin	40.07%	↑ 23.64%

	Q1 FY24	Q/Q Change
Revenue	$5.8B	↑ 115.22%
Net Income	$1.1B	↑ 0.83%
Net Profit Margin	18.77%	↓ 21.3%

	Q2 FY24	Q/Q Change
Revenue	$5.7B	↓ 0.91%
Net Income	$907.0M	↓ 16.64%
Net Profit Margin	15.79%	↓ 2.98%

	Q3 FY24	Q/Q Change
Revenue	$5.8B	↑ 0.96%
Net Income	$818.0M	↓ 9.81%
Net Profit Margin	14.11%	↓ 1.68%

	FY18	Y/Y Change
Total Assets	$47.8B	↑ 2.54%
Total Liabilities	$19.6B	↓ 3.33%

	FY19	Y/Y Change
Total Assets	$62.1B	↑ 29.79%
Total Liabilities	$31.8B	↑ 62.2%

	FY20	Y/Y Change
Total Assets	$76.2B	↑ 22.68%
Total Liabilities	$36.4B	↑ 14.42%

	FY21	Y/Y Change
Total Assets	$83.2B	↑ 9.22%
Total Liabilities	$38.0B	↑ 4.46%

	FY22	Y/Y Change
Total Assets	$84.4B	↑ 1.4%
Total Liabilities	$34.3B	↓ 9.86%

	FY23	Y/Y Change
Total Assets	$84.5B	↑ 0.16%
Total Liabilities	$31.0B	↓ 9.52%

	Q2 FY23	Q/Q Change
Total Assets	$84.9B	↓ 0.16%
Total Liabilities	$33.2B	↓ 1.12%

	Q3 FY23	Q/Q Change
Total Assets	$87.7B	↑ 3.34%
Total Liabilities	$35.3B	↑ 6.45%

	Q4 FY23	Q/Q Change
Total Assets	$84.5B	↓ 3.7%
Total Liabilities	$31.0B	↓ 12.23%

	Q1 FY24	Q/Q Change
Total Assets	$83.4B	↓ 1.29%
Total Liabilities	$30.0B	↓ 3.36%

	Q2 FY24	Q/Q Change
Total Assets	$78.6B	↓ 5.81%
Total Liabilities	$28.7B	↓ 4.35%

	Q3 FY24	Q/Q Change
Total Assets	$80.6B	↑ 2.62%
Total Liabilities	$29.3B	↑ 2.29%

	FY18	Y/Y Change
Operating Cash Flow	$4.0B	↑ 15.65%
Investing Cash Flow	$-2.9B	↑ 249.7%
Financing Cash Flow	$-797.0M	↓ 74.28%

	FY19	Y/Y Change
Operating Cash Flow	$4.0B	↓ 1.75%
Investing Cash Flow	$-1.2B	↓ 58.02%
Financing Cash Flow	$16.4B	↓ 2153.44%

	FY20	Y/Y Change
Operating Cash Flow	$6.2B	↑ 57.1%
Investing Cash Flow	$-21.2B	↑ 1615.45%
Financing Cash Flow	$1.0B	↓ 93.85%

	FY21	Y/Y Change
Operating Cash Flow	$8.4B	↑ 34.63%
Investing Cash Flow	$-13.0B	↓ 38.85%
Financing Cash Flow	$1.3B	↑ 28.73%

	FY22	Y/Y Change
Operating Cash Flow	$8.5B	↑ 1.93%
Investing Cash Flow	$-2.2B	↓ 82.8%
Financing Cash Flow	$-2.6B	↓ 298.46%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$1.9B	↓ 1.08%
Investing Cash Flow	$-431.0M	↑ 41.78%
Financing Cash Flow	$-208.0M	↓ 20.61%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$1.7B	↓ 13.19%
Investing Cash Flow	$-1.1B	↑ 146.87%
Financing Cash Flow	$2.4B	↓ 1274.52%

Danaher Technicals Summary

Sell

Neutral

Buy

Danaher is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Danaher Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Danaher Corp.	-3.66%	-11.44%	6.64%	-26.43%	57.78%
Idexx Laboratories, Inc.	1.7%	-13.53%	-18.41%	-26.53%	75.85%
Agilent Technologies Inc.	6.03%	6.59%	10.2%	-9.19%	69.55%
Thermo Fisher Scientific, Inc.	-2.02%	-6.92%	7.74%	-17.05%	67.19%
Iqvia Holdings Inc.	-6.36%	-6.56%	-6.54%	-24.67%	40.28%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Danaher Corp.	44.22	44.22	3.15	7.5	0.08	0.04	0.0	71.03
Idexx Laboratories, Inc.	42.93	42.93	4.74	10.73	0.59	0.23	NA	19.72
Agilent Technologies Inc.	31.62	31.97	2.44	5.24	0.25	0.08	0.01	20.53
Thermo Fisher Scientific, Inc.	32.68	33.55	2.05	21.7	0.13	0.05	0.0	128.08
Iqvia Holdings Inc.	26.66	26.66	1.05	11.12	0.22	0.05	NA	38.37

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Danaher Corp.	Buy	$170.4B	57.78%	44.22	16.39%
Idexx Laboratories, Inc.	Buy	$36.9B	75.85%	42.93	22.53%
Agilent Technologies Inc.	Buy	$40.0B	69.55%	31.62	21.75%
Thermo Fisher Scientific, Inc.	Buy	$199.2B	67.19%	32.68	14.48%
Iqvia Holdings Inc.	Buy	$36.9B	40.28%	26.66	9.17%

Danaher Dividend announcements

Danaher Dividends September, 2024
In the quarter ending September,2024. Danaher has declared dividend of $0.27
Read More

About Danaher

Danaher Corporation is an American globally diversified conglomerate founded by brothers Stephen and Mitchell Rales in 1984. Headquartered in Washington, D.C., the company designs, manufactures, and markets medical, industrial, and commercial products and services.

Organization	Danaher
Employees	61000
CEO	Mr. Steven M. Rales
Industry	Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables

Management People of Danaher

Name	Title
Mr. Steven M. Rales	Co-Founder & Chairman
Mr. Rainer M. Blair	President, CEO & Director
Mr. Mitchell P. Rales	Co-Founder & Director
Mr. Matthew R. McGrew	CFO & Executive VP
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.	Senior VP & Chief Science Officer
Ms. Georgeann F. Couchara	Senior Vice President of Human Resources
Mr. Christopher M. Bouda	VP & Chief Accounting Officer
Mr. John Bedford	Vice President of Investor Relations
Mr. Brian W. Ellis J.D.	Senior VP, General Counsel & Chief Compliance Officer
Mr. Daniel A. Raskas J.D.	Senior Vice President of Corporate Development

Important FAQs about investing in Danaher from India :

What is Danaher share price today?

Danaher (DHR) share price today is $234.34.

Can Indians buy Danaher shares?

Yes, Indians can invest in the Danaher (DHR) from India.

With INDmoney, you can buy Danaher at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Danaher at zero transaction cost.

How can I buy Danaher shares from India?

It is very easy to buy Danaher from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Danaher be purchased?

Yes, you can buy fractional shares of Danaher with INDmoney app.

What are the documents required to start investing in Danaher stocks?

To start investing in Danaher, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.